Enzalutamide

CAS Number: 915087-33-1

Molecular Formula: C21H16F4N4O2S

Purity: Enzalutamide 99.99%

About Enzalutamide

Enzalutamide (CAS No: 915087-33-1) serves as a critical active pharmaceutical ingredient and non-steroidal androgen receptor inhibitor, driving high-value demand across the global oncology therapeutics sector for metastatic and non-metastatic castration-resistant prostate cancer formulations. The global commercial mark...

Synonyms

4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-(methyl-d3)benzamide
4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-benzamide
enzalutamide
enzalutamide D3
HC 1119

View all

Enzalutamide Specifications

CAS Number

915087-33-1

Molecular Formula

C21H16F4N4O2S

Molecular Weight

464.44 g/mol

IUPAC Name

4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide

PubChem CID

15951529

HSN No

30049099

CAS Number

915087-33-1

Molecular Formula

C21H16F4N4O2S

Molecular Weight

464.44 g/mol

IUPAC Name

4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide

PubChem CID

15951529

HSN No

30049099

Molecular Weight

464.44 g/mol

Purity

Enzalutamide 99.99%

Prostate Cancer Therapy

An oral androgen receptor inhibitor used in the treatment of various stages of advanced prostate cancer, including metastatic and non-metastatic castration-resistant and castration-sensitive forms

Feminizing Hormone Therapy

An antiandrogen agent used as part of hormone therapy regimens for transgender women

Breast Cancer Research

An investigational therapeutic agent evaluated in clinical trials for androgen receptor-positive, triple-negative breast cancer

Polycystic Ovary Syndrome Treatment

A potential therapeutic option evaluated for managing hirsutism and hyperandrogenism in women with polycystic ovary syndrome

4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-(methyl-d3)benzamide
4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-benzamide
enzalutamide
enzalutamide D3
HC 1119